Blog

Credibly reintermediate backend ideas for cross-platform models. Continually reintermediate integrated processes through technically sound intellectual capital.
Astellas Announces the Opening of Its New Gene Therapy Manufacturing Facility in North Carolina

Astellas Pharma Inc has announced the opening of a new late stage clinical and commercial manufacturing facility in Sanford, North Carolina, US. The facility will allow the company to expand its resources and team to establish a robust, global supply chain and expand its therapeutic and geographic scope. Article Summary The new 135,000 square-foot state-of-the-art...

Center for Breakthrough Medicines Accelerates Plans to Build the Largest Cell Therapy Manufacturing Operation in the World

The Center for Breakthrough Medicines (CBM) in partnership with the Discovery Labs has accelerated the plans to build capacity to manufacture more than 10,000 patient therapies in direct response to the critical shortage of cell therapy supply, which will help patients win their courageous battles against cancer. Article Summary Planning has begun on a massive...

Prescient Therapeutics Unveils its New Cell Therapy Platform – CellPryme-M

A clinical-stage oncology company Prescient Therapeutics (PTX) has launched its second cell therapy platform, CellPryme-M, which produces superior cells with greater cancer killing activity. This platform opens commercial opportunities for the company to incorporate it into third-party manufacturing processes. Article Summary PTX has developed this new platform technology in association with its research partner, Peter...

The European Investment Bank (EIB) has provided €75 million to the Institut Pasteur de Dakar for the construction of a new vaccine manufacturing facility.

Excerpt Large-scale funding for the Institut Pasteur de Dakar’s new vaccine manufacturing facility, a leader in the area in Africa. The facility, which would produce up to 300 million doses per year against COVID-19 and other endemic diseases, is projected to considerably reduce Africa’s reliance on imported vaccines and support equal access to medicines. This...

World Bank Support for Country Access to COVID-19 Vaccines

Excerpt The World Bank has approved $9.5 billion in operations to assist vaccination rollout in 77 countries as of June 15, 2022. Article Summary The World Bank Group is collaborating with partners on the world’s largest vaccine programme to combat the COVID-19 pandemic. The World Bank’s Board of Executive Directors adopted a $6 billion Global...

Nippon Express Launches Ultra-low Temperature-controlled Logistics Service for Pharmaceutical Industry

Excerpt: Nippon Express Co., Ltd. (hereinafter “Nippon Express”), a group company of Nippon Express Holdings, Inc., launched on May 30 a logistics service capable of handling goods requiring ultra-low temperatures (-20 C to -85 C) for the pharmaceutical industry.   Article Summary: As a priority approach for the core business growth strategy outlined in the...

Samsung Biologics to build first overseas factory in US

Excerpt: Samsung Biologics CEO John Rim said Monday the US states of California, North Carolina, Washington and Texas are the strongest candidates the South Korean contract manufacturing organization is considering for its first overseas production facility.   Article Summary: Pointing out that some of the US’ major bio clusters are located in those four states,...

GXO Logistics to open warehouse for pharmaceutical sector

Excerpt: Logistics provider GXO plans to open a 20,000m2  warehouse dedicated to the pharmaceutical sector in Caleppio di Settala in Milan, Italy, by the end of June 2022. Article Summary: The location was chosen for its proximity to major surface transportation arteries to help enable pharmaceutical companies to meet the stringent lead times required for...